Stable high-concentration injection containing pyrazolone derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7211596
APP PUB NO 20040162330A1
SERIAL NO

10477275

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An injection which contains as the active ingredient a pyrazolone derivative which typically is Edaravone, a physiologically acceptable salt thereof, or a hydrate or solvate of either in an amount of 3 to 60 mg/mL. It is excellent in long-term stability, product storage, and suitability for use.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MITSUBISHI PHARMA CORPORATIONCHUO-KU OSAKA-SHI

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chiba, Masatoshi Tokyo, JP 3 22
Matsuo, Naoki Tokyo, JP 27 156
Yoshida, Hiroshi Tokyo, JP 860 8854

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 9 Citation Count
  • A61K Class
  • 8.93 % this patent is cited more than
  • 18 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges30718326412821326750302016134901 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +010020030040050060070080090010001100120013001400150016001700180019002000

Forward Cite Landscape

Load Citation